Anteo Diagnostics

24 February 2016

As published in CK Momentum Issue 9 (Click here to download)

John Toigo and Kate Gardner in our Corporate Team, recently acted as the Australian lawyers for Anteo Diagnostics Limited (ASX:ADO), an Australian listed biotech company, in its acquisition of 100% of DIAsource ImmunoAssays S.A., a Belgium based diagnostics company, which operates in 75 countries.

This is a transformational acquisition for Anteo, providing it with an established global distribution platform, manufacturing capabilities and a significantly broadened product range. As part of this transaction John and Kate also advised Anteo on its capital raising activities (including a rights issue) to fund the acquisition.


This bulletin is produced as general information in summary for clients and subscribers and should not be relied upon as a substitute for detailed legal advice or as a basis for formulating business or other decisions. ClarkeKann asserts copyright over the contents of this document. This bulletin is produced by ClarkeKann. It is intended to provide general information in summary form on legal topics, current at the time of publication. The contents do not constitute legal advice and should not be relied upon as such. Formal legal advice should be sought in particular matters. Liability limited by a scheme approved under professional standards legislation. Privacy Policy


…and we’ll email you valuable insights into issues affecting you and your business.

More Insights

Unfair Contract Terms Reform Alert (2022)

Unfair Contract Terms Reform Alert (2022)

There are changes happening! Significant changes are set to shake up the law of Unfair Contract Terms in small business standard form contracts. The changes come into effect on 9 November 2023 and will introduce serious penalties for businesses that use and rely on...

read more